New hope for HIV patients who failed long-acting shots: switching to a daily pill
Disease control
Not yet recruiting
This study looks at whether switching to a daily pill containing bictegravir, emtricitabine, and tenofovir alafenamide (BIC/FTC/TAF) can help people with HIV who previously did not respond to a long-acting injectable treatment (CAB/RPV LAI). The study includes 30 adults and will …
Sponsor: Cristina Mussini • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC